You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Drip-infusion

Showing 1 - 25 of 7,383
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drip-infusion of Remifentanil for RIH

Completed
  • Hyperalgesia
  • Taipei, Taiwan
    TriService General Hospital
May 13, 2020

Aneurysmal Subarachnoid Hemorrhage, Neurobehavioral Manifestations, Vasospasm, Intracranial Trial in United States (Continuous

Suspended
  • Aneurysmal Subarachnoid Hemorrhage
  • +4 more
  • Continuous Low-Dose IV Unfractionated Heparin Infusion
  • New Haven, Connecticut
  • +8 more
Feb 17, 2022

Intrauterine Growth Retardation, Feeding Patterns, Splanchnic Hypoperfusion Trial in Eskisehir (The effect of drip versus

Completed
  • Intrauterine Growth Retardation
  • +2 more
  • The effect of drip versus intermittent feeding on splanchnic oxygenation
  • Eskisehir, Turkey
    Ozge Surmeli Onay
Aug 23, 2022

Acute Ischemic Stroke Trial in Barcelona (Tenecteplase)

Recruiting
  • Acute Ischemic Stroke
  • Barcelona, Spain
    Hospital Universitari Vall d'Hebron
Nov 22, 2022

Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 24, 2023

Safety and Efficacy of Trastuzumab BS

Not yet recruiting
  • Gastric Cancer
  • TRASTUZUMAB BS
  • (no location specified)
Dec 19, 2022

Acute Pain in Herpes Zoster Trial in Japan (NPC-06, Placebo)

Not yet recruiting
  • Acute Pain in Herpes Zoster
  • Urayasu, Chiba, Japan
  • +19 more
Jul 29, 2022

ATGAM General Investigation

Not yet recruiting
  • Aplastic Anemia
  • Anti-human thymocyte immunoglobulin, equine
  • (no location specified)
Sep 8, 2023

Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Zoledronic acid)

Recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • Zoledronic acid
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 10, 2023

Trauma Injury, Pain, Opioid Use Trial in Houston (Ketamine plus usual care, Usual Care)

Active, not recruiting
  • Trauma Injury
  • +2 more
  • Ketamine plus usual care
  • Usual Care
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Feb 28, 2022

Subarachnoid Hemorrhage, Cerebral Aneurysm, Vasospasm, Intracranial Trial in Detroit (clevidipine)

Withdrawn
  • Subarachnoid Hemorrhage
  • +2 more
  • Detroit, Michigan
    Henry Ford hospital
Jan 30, 2023

Healthy Volunteers Trial (Aom0319)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Dec 2, 2022

Ovarian Cancer, Cholangiocarcinoma Recurrent, Mesothelioma, Malignant Trial (SynKIR-110, Autologous T cells Transduced with

Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
  • (no location specified)
Oct 5, 2022

Chemo-induced Peripheral Neuropathy Trial (thrombomodulin alfa, Placebo)

Withdrawn
  • Chemotherapy-induced Peripheral Neuropathy
  • thrombomodulin alfa
  • Placebo
  • (no location specified)
Feb 2, 2022

COVID-19 Trial (Adrecizumab (HAM 8101), Placebo)

Not yet recruiting
  • COVID-19
  • Adrecizumab (HAM 8101)
  • Placebo
  • (no location specified)
Jun 29, 2022

Pancreatic Adenocarcinoma Trial in Kochi (GS, GnP)

Recruiting
  • Pancreatic Adenocarcinoma
  • Kochi, Japan
    Takehiro Okabayashi
Feb 24, 2022

Hypertension, Cardiovascular Diseases Trial in Kansas City (Ascorbic acid solution (American Regent Laboratories Inc.), Saline)

Recruiting
  • Hypertension
  • Cardiovascular Diseases
  • Ascorbic acid solution (American Regent Laboratories Inc.)
  • Saline
  • Kansas City, Kansas
    University of Kansas Medical Center
Mar 10, 2022

Pleural Effusion, Single-ventricle Trial in Oak Lawn (Vasopressin, Normal Saline)

Withdrawn
  • Pleural Effusion
  • Single-ventricle
  • Oak Lawn, Illinois
    Advocate Children's Hospital
Dec 10, 2022

HIV/AIDS Trial in Hefei (Albuvirtide)

Not yet recruiting
  • HIV/AIDS
  • Hefei, China
    The Second Hospital of Anhui Medical University
Jan 12, 2022

Brain Metastases, Radiotherapy Side Effect, Cognitive Impairment Trial in Guangzhou (Monosialotetrahexosyl ganglioside (GM1),

Recruiting
  • Brain Metastases
  • +4 more
  • Monosialotetrahexosyl ganglioside (GM1)
  • Control
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 3, 2021

Carcinoma, Non-Small Cell Lung Trial (sequential DEB-BACE and Arotinib and Tirelizumab, DEB-BACE alone)

Not yet recruiting
  • Carcinoma, Non-Small Cell Lung
  • sequential DEB-BACE and Arotinib and Tirelizumab
  • DEB-BACE alone
  • (no location specified)
May 14, 2022

Metastatic Microsatellite-stable Colorectal Cancer Trial in China (Experimental drug, Control Rx)

Recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • Experimental drug
  • Control Rx
  • Hefei, Anhui, China
  • +11 more
Mar 13, 2023

CCHF Trial (Favipiravir, Ribavirin)

Not yet recruiting
  • CCHF
  • (no location specified)
Jul 7, 2023

Advanced NSCLC Trial in China (SHR-8068;Adebrelimab, SHR-8068;adebrelimab and platinum-based chemo, Adebrelimab;platinum-based

Recruiting
  • Advanced Non-small Cell Lung Cancer
  • Hefei, Anhui, China
  • +17 more
Aug 17, 2022

Rheumatoid Arthritis Trial in Changchun (BAT1806 injection)

Completed
  • Rheumatoid Arthritis
  • BAT1806 injection
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Nov 16, 2021